Literature DB >> 30851941

Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.

Vikas Thondapu1, Osamu Kurihara1, Taishi Yonetsu2, Michele Russo1, Hyung Oh Kim1, Hang Lee3, Tsunenari Soeda4, Yoshiyasu Minami5, Ik-Kyung Jang6.   

Abstract

Statins are widely used to lower cholesterol and to reduce cardiovascular events. Whether all statins have similar effects on plaque stabilization is unknown. We aimed to investigate coronary plaque response to treatment with different statins that result in similar lipid reduction using serial multimodality intracoronary imaging. Patients with de novo coronary artery disease requiring intervention were randomized to rosuvastatin 10mg (R10) or atorvastatin 20mg (A20) daily. Optical coherence tomography and intravascular ultrasound were performed at baseline, 6 months, and 12 months. Untreated nonculprit plaques were analyzed by optical coherence tomography for thin-cap fibroatheroma, minimum fibrous cap thickness, lipid arc, and lipid length. Total and percent atheroma volume, respectively were analyzed by intravascular ultrasound. Forty-three patients completed the protocol (R10: 24 patients, 31 plaques; A20: 19 patients, 30 plaques). The decrease in serum lipids was similar. From baseline to 6 months to 12 months, minimum fibrous cap thickness increased in the R10 group (61.4 ± 15.9 µm to 120.9 ± 57.9 µm to 171.5 ± 67.8 µm, p <0.001) and the A20 group (60.8 ± 18.1 µm to 99.2 ± 47.7 µm to 127.0± 66.8 µm, p <0.001). Prevalence of thin-cap fibroatheroma significantly decreased in the R10 and A20 groups (-48% and -53%, respectively, p <0.001 for intragroup comparisons). Only the R10 group had a decrease in macrophage density (-23%, p = 0.04) and microvessels (-12%, p = 0.002). Total atheroma volume decreased in the R10 group (109.2 ± 62.1 mm3 to 101.8 ± 61.1 mm3 to 102.5 ± 62.2 mm3, p = 0.047) but not in the A20 group (83.3 ± 48.5mm3 to 77.6 ± 43.0 mm3 to 77.9 ± 48.6 mm3, p = 0.07). In conclusion, although both statins demonstrated similar reductions in lipid profiles, the rosuvastatin group showed more rapid and robust plaque stabilization, and regression of plaque volume compared to the atorvastatin group.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30851941     DOI: 10.1016/j.amjcard.2019.02.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Variability in blood lipids affects the neutrophil to lymphocyte ratio in patients undergoing elective percutaneous coronary intervention: a retrospective study.

Authors:  Liding Zhao; Tian Xu; Ya Li; Yi Luan; Qingbo Lv; Guosheng Fu; Wenbin Zhang
Journal:  Lipids Health Dis       Date:  2020-06-03       Impact factor: 3.876

2.  Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities.

Authors:  Xinxin Zhang; Yating Qin; Xiaoning Wan; Hao Liu; Chao Lv; Weibin Ruan; Lin He; Li Lu; Xiaomei Guo
Journal:  J Transl Med       Date:  2021-02-10       Impact factor: 5.531

3.  New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.

Authors:  Jah Yeon Choi; Cheol Ung Choi; Byoung Geol Choi; Yoonjee Park; Dong Oh Kang; Won Young Jang; Woohyeun Kim; Jin Oh Na; Jin Won Kim; Eung Ju Kim; Seung-Woon Rha; Chang Gyu Park; Hong Seog Seo; Myung Ho Jeong; Sung-Chull Chae; In-Whan Seong; Chang-Hwan Yoon; Kwang Soo Cha; Seok Kyu Oh
Journal:  BMC Pharmacol Toxicol       Date:  2021-02-04       Impact factor: 2.483

4.  The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis.

Authors:  Yingrui Li; Songbai Deng; Bin Liu; Yulin Yan; Jianlin Du; Yu Li; Xiaodong Jing; Yajie Liu; Jing Wang; Jun Du; Qiang She
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

Review 5.  Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.

Authors:  Michal Kowara; Agnieszka Cudnoch-Jedrzejewska
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

6.  Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.

Authors:  Xiaodan Zhang; Lu Xing; Xiaona Jia; Xiaocong Pang; Qian Xiang; Xia Zhao; Lingyue Ma; Zhiyan Liu; Kun Hu; Zhe Wang; Yimin Cui
Journal:  Cardiovasc Ther       Date:  2020-04-23       Impact factor: 3.023

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.